Dimethylformamide → HCID 86722692, 화합물
반응식
[Cl:1][C:2]1[CH:7]=[C:6]([Cl:8])[CH:5]=[CH:4][C:3]=1[CH2:9][OH:10].[C:11]([O:17][CH2:18][N:19]1[CH:23]=[C:22]([CH2:24][CH2:25][CH2:26][C:27](=[O:35])[NH:28][CH:29]2[CH2:34][CH2:33][NH:32][CH2:31][CH2:30]2)[N:21]=[N:20]1)(=[O:16])[C:12]([CH3:15])([CH3:14])[CH3:13].CN([CH:39]=[O:40])C>CCOC(C)=O>[C:11]([O:17][CH2:18][N:19]1[CH:23]=[C:22]([CH2:24][CH2:25][CH2:26][C:27]([NH:28][CH:29]2[CH2:30][CH2:31][N:32]([C:39]([O:10][CH2:9][C:3]3[CH:4]=[CH:5][C:6]([Cl:8])=[CH:7][C:2]=3[Cl:1])=[O:40])[CH2:33][CH2:34]2)=[O:35])[N:21]=[N:20]1)(=[O:16])[C:12]([CH3:15])([CH3:14])[CH3:13]참가 물질
5
반응 조건
- 온도
- 50 °C
실험 절차
To a stirred solution of commercially available (2,4-dichlorophenyl)methanol (137 mg, 0.774 mmol) in DMF (2 mL) at RT was added CU (125 mg, 0.774 mmol). The reaction mixture was allowed to heat at 50° C. for 20 hrs. (4-(4-oxo-4-(piperidin-4-ylamino)butyl)-1H-1,2,3-triazol-1-yl)methyl pivalate (Example 37, step 5)(272 mg, 0.774 mmol) was added and the reaction mixture was stirred at 50° C. for 10 hrs. The reaction mixture was diluted with EtOAc and washed with a saturated solution of sodium bicarbonate and brine, dried over MgSO4, filtered and concentrated under reduced pressure. Purification was carried out by chromatography on silica eluting with 0-100% EtOAc in iso-hexane to afford the title product;
후처리
- washwashed with a saturated solution of sodium bicarbonate and brine
- dry with materialdried over MgSO4
- filtrationfiltered
- concentrationconcentrated under reduced pressure
- customPurification
출처 및 근거
- ORD 기록
- ord-76a2d418de294e48aa58978743cbaa2d
- 출처 데이터셋
- uspto-grants-2016_08
- 특허 번호
- US09409895B2
반응 노트
불러오는 중…